USP Will Consider Setting Pharmacy Compounding Standards
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. Pharmacopeia will consider a resolution on setting pharmacy compounding standards at its upcoming 2005 convention
You may also be interested in...
USP Monographs Should Be Developed By Public/Private Partnership, Congress Says
FDA is urged to seek adequate funding in the FY 2006 budget request to support the effort to increase the number of formal monographs for drug compounding, the report for the FY 2005 spending bill states. The bill provides FDA with $1.79 bil.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.
AstraZeneca Joins The $35 Inhaler Club; Medicare Patients Waiting On Congress For Membership
AZ’s move follows Boehringer’s announcement earlier this month and parallels what insulin sponsors did – but almost in reverse. For inhalers, political pressure on out-of-pocket costs has produced copay caps in the commercial market first, not Medicare.